Navigation Links
Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
Date:6/8/2011

HAYWARD, Calif., June 8, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it has completed the previously announced underwritten public offering of 6,666,667 shares of its common stock, offered at a price of $7.50 per share.  In addition, the Company has sold 1,000,000 shares of its common stock at a price of $7.50 per share pursuant to the underwriters' option to purchase additional shares, resulting in a total public offering of 7,666,667 shares.  The net proceeds to the Company from the sale of shares in this offering, after deducting customary underwriting discounts and commissions, were approximately $54 million.    

Anthera intends to use the net proceeds from this offering for general corporate purposes.

Citi and Leerink Swann LLC acted as joint book-running managers in the offering and Canaccord Genuity acted as lead co-manager in the offering.  

The securities described above were offered by the Company pursuant to a shelf registration statement previously filed with, and declared effective by, the Securities and Exchange Commission (the "SEC") on March 11, 2011.  A final prospectus supplement relating to the offering was filed with the SEC and is available on the SEC's website at http://www.sec.gov.  Copies of the final prospectus supplement relating to these securities may be obtained from the prospectus department of Citi, 140 58th Street, 8th Floor, Brooklyn, New York 11220, Telephone: (800) 831-9146, or by email at batprospectusdept@citi.com.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful pri
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
2. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
3. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
4. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
5. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
6. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
7. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015  Michigan brothers Dominique Larkin , 23, and ... ventricular dysplasia, or ARVD, a disease that causes irregular heart ... young athletes. In 2007, doctors discovered the condition ... later tested Dominique and found his "condition was just as ... story in The Ann Arbor News , part of ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research ... announced the addition of the "Global Ultrasound ... , The Global Ultrasound ... 5.79% over the period 2014-2019 Ultrasound ... sound waves. Ultrasound systems are extensively used by ...
(Date:3/3/2015)... 2015   VWR  (NASDAQ:  VWR), a leading, ... announced today the expansion of its distribution agreement ... allows VWR increased access to NEB,s growing product ... and Puerto Rico.  In addition, customers will now ... platform, sales organization, and VWRCATALYST, our onsite services ...
Breaking Medicine Technology:Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2VWR Announces Expansion of Distribution Agreement with New England Biolabs 2
... Nov. 7, 2011 Children,s Hospitals and Clinics of Minnesota ... will give patients immediate access to specialists when they need ... shorten transport time by as much as 15 minutes, by ... Abbott Northwestern Hospital though a tunnel to Children,s, a distance ...
... UNION CITY, Calif., Nov. 7, 2011 Abaxis, Inc. ... analysis systems, announced today that Kenneth Aron, Chief Technology ... York II Emerging Growth Institutional Investor Forum on Thursday, ... will be held at the Grand Hyatt New York ...
Cached Medicine Technology:Children's Hospitals and Clinics of Minnesota Opens New Helipad on its Minneapolis Campus 2Abaxis, Inc. to Present at Sidoti & Company's New York II Emerging Growth Institutional Investor Forum 2
(Date:3/3/2015)... (PRWEB) March 03, 2015 Today, Steve ... former Seattle Seahawks wide receiver, announced the donation of ... timing with Brain Injury Awareness Month. In an effort ... and the importance of brain health, Rice and Weatherford ... and the need to make brain health a priority ...
(Date:3/3/2015)... Angeles, Ca (PRWEB) March 03, 2015 Dan ... with a special focus on capital crimes, recently spoke ... “American Sniper” murder trial. The hosts of the Independent Journal ... knew his history working first as a prosecutor and now ... insight into the decisions made in the trial and sentencing ...
(Date:3/3/2015)... The human augmentation market is mainly driven by ... augmentation sector is predicted to outpace the in-built augmentation ... , The eye-wear sector dominates the North American ... new products launches in the region. Furthermore, strong economy ... well as the rising demand for advantageous products in ...
(Date:3/3/2015)... While it is clear that the prospect ... Canadian drivers are signing up to UBI policies, more ... be enticed. Due to current regulations, the application of ... Its full capability is starting to be realised ... emergency breakdown services are at the top of the ...
(Date:3/3/2015)... 03, 2015 DePuy Pinnacle hip ... version of the artificial hip system caused recipients ... move forward in the federal multidistrict litigation underway ... According to the most recent Master Case List ... 7,350 Pinnacle hip replacement lawsuits are now pending ...
Breaking Medicine News(10 mins):Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4
... has directed the state prisons department to provide ayurvedic treatment ... 1998// serial blasts Abdul Nasser Mahdhani in the central prison ... arrest in March 1998, 45 days after the serial blasts, ... blood pressure, diabetes, spinal proble and weight loss. He also ...
... of India wants the Government and people to work together ... donation. In India., ,Inaugurating the blood bank of ... asked the government and people to work in tandem for ... organs must be encouraged to save precious lives, especially that ...
... gene that facilitates the spread of malignant melanoma, a ... speed the discovery of hard-to-find cancer genes. ,A ... Lynda Chin, MD, report that the gene, NEDD9, is ... that have metastasized, but not in primary melanomas that ...
... subject as sex is, perhaps vying with each other for ... known - responsible //for many diseases, failed pregnancy, miscarriage, etc. ... host of problems, like ADHD in the child and premature ... memory and hormonal cycles. ,Women seem to be twice ...
... that the antipsychotic drug, clozapine has some very concerning ... available. ,"Clozapine is the last hope for ... study suggests that patients who need the most effective ... said J. Steven Lamberti, the lead author of the ...
... Paris have concluded that at least one decade is needed ... Dr. David Fedson, former professor// of medicine at the University ... was nothing short of a catastrophe for the public. ... work with for three years and after three years this ...
Cached Medicine News:Health News:Researchers have Identified the Gene that Spreads Skin Cancer 2
... for applications in the field of point of ... used as a back-up instrument in routine pathology ... safety clamps for the cover, the CM1100 can ... optional 12-volt transformer, it can be run on ...
The HM 550 series is a uniquely progressive concept for use with frozen specimens of all types. User applications define module selection and make even serial sectioning enjoyable....
... advanced smart processor for paraffin infiltration of ... Proven and enhanced technology with an innovative ... the hallmark of the Leica ASP200. Many ... includes a variety of SMART features to ...
... A totally new concept in a power ... and sliding microtomes. Power assisted horizontal movements ... moving across the knife edge. Duplicate controls ... or right hand while the operating levers ...
Medicine Products: